Scipher Medicine
PrivateLast Round
PIPE
Jul 8, 2026
Est. Valuation
$180M
Total Funding Raised
$232.85M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Scipher Medicine is a biotechnology company that provides a precision medicine platform to identify the most effective drug for patients with autoimmune diseases based on their unique biological profiles and molecular signature tests.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scipher Medicine Comparables
Compare Scipher Medicine with similar companies based on industry and business-model similarity.
Scipher Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Jul 8, 2026 | ||||
| Series D Extension | Jul 30, 2024 | ||||
| Series D | Feb 24, 2022 | ||||
| Series C | Mar 24, 2021 | ||||
| Series B | Feb 19, 2020 | ||||
Series A | Sep 6, 2018 |
Key People
Founding team and executive leadership
Scipher Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granpool Innovative Investments | Series B, Seed |
| HV Fund | Series D |
| Kaiser Permanente Ventures | Series B |
| Khosla Ventures | Series B, Series C, PIPE, Series D, Series A |
| TD Securities | Series D |
| Blue Owl Capital | Series D |
| Neuberger Berman | PIPE, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 70% MoM.
- Apr 29, 2025
Partnered with InnoSIGN Inc. to analyze immune-mediated diseases.
Recent news
Latest coverage and updates
- attends_eventAug 31, 2026
Scipher Medicine will attend event H.C. Wainwright Conference on Sep 14th '26.
Scipher Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Scipher Medicine's valuation, stock price, and market status.
Is Scipher Medicine a public or private company?
Scipher Medicine is a private company.
What is the current stock price of Scipher Medicine?
Scipher Medicine is a private company with no public stock price. No recent secondary market data is available.
How much is Scipher Medicine worth (valuation)?
Scipher Medicine's valuation is estimated at $490.0M based on funding round data.
Can I buy Scipher Medicine stock?
Scipher Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Scipher Medicine's last funding round?
Scipher Medicine's most recent funding round was Series D Extension on February 24, 2022.
Who are the main investors in Scipher Medicine?
Key investors in Scipher Medicine include Khosla Ventures, TD Securities, Blue Owl Capital, Optum Ventures, aMoon.
Will Scipher Medicine IPO soon?
No public IPO plans have been announced for Scipher Medicine.
How can I track Scipher Medicine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scipher Medicine's secondary market activity and sign up for updates.